Skip to main content
. Author manuscript; available in PMC: 2015 Oct 29.
Published in final edited form as: Life Sci. 2014 Sep 28;116(2):59–66. doi: 10.1016/j.lfs.2014.09.015

Table II.

neutrophil subpopulations in diseases

N1/N2 Disease Model Subjects Key Findings References
N1 Tuberculous pleurisy Guinea pigs TGF-β neutralization increases neutrophils in pleural exudate. Allen et al., 2008 [69]
N1 Tumor Mouse TGF-β blockade reduces tumor metastasis. Kazemfar et al., 2009 [70]
N2 NA Human Regulatory T cells inhibit neutrophils survival and their ROS and cytokine production, which is confirmed at least partially mediated by and IL-10. Lewkowicz et al., 2006 [65]
N2 NA Human TGF-β1 suppresses neutrophil degranulation to prevent them from initiating an inflammatory response. Shen et al., 2007 [64]
N2 Stroke Mouse PPAR-γ activation with rosiglitazone induces “N2” neutrophils. Cuartero et al. 2013 [63]
N/N2 Tumor Mouse Blockade of TGF-β promotes tumor-associated neutrophils with an anti-tumor phenotype, which is referred as N1. TGF-β in tumor microenvironment induces a pro-tumor neutrophils, N2. Fridlender et al., 2009 [62]

NA, not available